Bicara Therapeutics Inc.

BCAX

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001628280-26-015423
Filing date: Mar 5, 2026
Earliest execution date: Mar 3, 2026
Reporting Owners: Cohlhepp Ryan (COO)

Summary

Type

Sell

Net shares

-17,392

% of shares

-7.82%

Amount (USD)

$315,892

Insider confidence score

28.8 out of 100

Positive

  • Under Rule 10b5-1 trading plan

Negative

  • Very large scheduled sell (<10% of shares)
  • Large sell amount ($250K+)

Stock transactions

Transaction 1

Security

Common Stock

Action

Exercise

Date

2026-03-03

Code

M

Net shares

+12,892.0

Price per Share

$3.79

Amount (USD)

$48,858.10

Acquired/Disposed

Acquired

Shares Owned Before

209,641.0

Shares Owned After

222,533.0

Transaction 2

Security

Common Stock

Action

Sell

Date

2026-03-03

Code

S

Net shares

-12,892.0

Price per Share

$18.16

Amount (USD)

$234,158.69

Acquired/Disposed

Disposed

Shares Owned Before

222,533.0

Shares Owned After

209,641.0

Transaction 3

Security

Common Stock

Action

Sell

Date

2026-03-03

Code

S

Net shares

-4,500.0

Price per Share

$18.16

Amount (USD)

$81,733.95

Acquired/Disposed

Disposed

Shares Owned Before

209,641.0

Shares Owned After

205,141.0

Derivative Transactions

Transaction 1

Security

Stock Option (Right to Buy)

Action

Exercise

Date

2026-03-03

Code

M

Net shares

-12,892.0

Acquired/Disposed

Disposed

Shares Owned Before

138,226.0

Shares Owned After

125,334.0

Filing's footnotes

1. This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

3. The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date.

ℹ️ Filed under Rule 10b5-1 trading plan

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.